Pushing AR toward better outcomes in breast and prostate cancers [ 2018 - 2021 ]

Research Grant

Researchers: Prof Wayne Tilley (Principal investigator) ,  A/Pr Elgene Lim ,  A/Pr Jason Carroll ,  Dr Luke Selth ,  Dr Theresa Hickey

Brief description Breast and prostate cancers kill >6000 Australians each year. These cancers are strikingly similar, both driven by hormone receptors that have ‘gone bad’. Current therapies aim to eradicate the receptors. While often effective, therapeutic resistance is common and results in fatal disease. We aim to develop new, less toxic treatments that switch receptor behaviour from good to bad, without destroying them. This should improve quality of life, while preventing drug resistance and loss of lives.

Funding Amount $AUD 1,012,736.54

Funding Scheme Project Grants

Notes Standard Project Grant